|
OMEPRAZOLE IMPURITY DOMEPRAZOLE SULPHONE EP STANDARD
|
奧美拉唑雜質(zhì)
|
|
|
Canagliflozin
|
卡格列凈(無水合物)
|
842133-18-0
|
|
Atorvastatin Calcium Impurity VI Degradation Product
|
氧氟沙星光降解雜質(zhì)
|
151377-74-1
|
|
LY2835219
|
LY2835219 中間體一
|
1231930-42-9
|
|
(S)-Cinacalcet hydrochloride
|
S-鹽酸西那卡塞
|
1217809-88-5
|
|
OseltaMivir iMpurity E
|
奧司他韋雜質(zhì)
|
903907-74-4
|
|
Mycophenolate IMpurity
|
霉酚酸雜質(zhì)
|
|
|
Acebutolol EP Impurity D
|
醋丁洛爾雜質(zhì)
|
|
|
Diclofenac
|
雙氯芬酸雜質(zhì)
|
|
|
Quinapril IMpuriy
|
喹那普利雜質(zhì)
|
|
|
Carfilzomib
|
卡非佐米
|
868540-17-4
|
|
Ciprofloxacin impurity
|
環(huán)丙沙星雜質(zhì)
|
|
|
AP26113
|
AP26113
|
1197958-12-5
|
|
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan
|
(3S)-3-[4-[(2-氯-5-碘苯基)甲基]苯氧基]四氫呋喃(依帕列凈中間體);依帕列凈雜質(zhì) C;(S)-3-(4-(2-氯-5-碘芐基)-苯氧基)-四氫呋喃
|
915095-94-2
|
|
Nebivolol O-Beta-D-Glucuronide
|
奈必洛爾雜質(zhì)
|
|
|
SalbutaMol IMpurity C
|
沙丁胺醇雜質(zhì)
|
|
|
Sertraline IMpurity (SRTRC-3)
|
舍曲林雜質(zhì)
|
|
|
Pantoprazole IMpurity (Mixture of IMpurity D and F)
|
泮托拉唑雜質(zhì)
|
|
|
Pitavastatin IMpurity 4 (PP-4)
|
匹伐他汀雜質(zhì)
|
1422058-54-5
|
|
Pregabalin IMpurity
|
普瑞巴林雜質(zhì)
|
159029-27-3
|
|
2',3'-Didehydro Lovastatin
|
洛伐他汀雜質(zhì)
|
|
|
Group Doppler impurity
|
群多普利雜質(zhì)
|
|
|
Naltrexone hydrochloride impurity C
|
鹽酸納曲酮雜質(zhì)c
|
|
|
CO-1686
|
CO-1686 中間體二
|
68621-88-5
|
|
WZ8040
|
WZ8040
|
1214265-57-2
|
|
CO-1686
|
CO1686
|
1374640-70-6
|
|
Glimepiride impurity
|
格列美脲雜質(zhì)
|
|
|
Nizatidine impurity
|
尼扎替丁雜質(zhì)
|
|
|
Valaciclovir iMpurity
|
伐昔洛韋雜質(zhì)
|
|
|
J
|
替米沙坦雜質(zhì)J
|
1026258-58-1
|
|
OMEPRAZOLE IMPURITY DOMEPRAZOLE SULPHONE EP STANDARD
|
蘭索拉唑雜質(zhì)
|
1083100-27-9
|
|
Sildenafil Aldehyde IMpurity
|
西地那非雜質(zhì)
|
845302-49-0
|
|
Canagliflozin
|
卡格列凈（半水合物）
|
928672-86-0
|
|
CO-1686
|
CO-1686 中間體一
|
1374507-23-9
|
|
Pravastatin iMpurity (6a-OH-iso-coMpactin OH acid)
|
普伐他汀雜質(zhì)
|
|
|
Alfuzosin impurity
|
阿夫唑嗪雜質(zhì)
|
|
|
Diltiazem impurity
|
地爾硫卓雜質(zhì)
|
115992-91-1
|
|
rac-3-Des[2-(dimethylamino)ethyl]-Zolmitriptan 3-Acetic Acid-d3
|
佐米曲普坦雜質(zhì)
|
1432902-38-9
|
|
Raloxifene EP IMpurity
|
雷洛昔芬雜質(zhì)
|
1700655-64-6
|
|
Rabeprazole iMpurity (Chloro interMediate
|
雷貝拉唑
|
117976-89-3
|
|
1,2,3-Trithiane-4-pentanoic Acid
|
硫辛酸雜質(zhì)A
|
1204245-29-3
|
|
Perindopril Impurity
|
培哚普利雜質(zhì)
|
|
|
TranexaMic Acid iMpurity
|
氨甲環(huán)酸雜質(zhì)
|
|
|
Meloxicam impurity
|
美洛昔康雜質(zhì)
|
|
|
Sumatriptan
|
舒馬曲坦雜質(zhì)
|
|
|
WZ4002
|
WZ4002
|
1213269-23-8
|
|
EMpagliflozin
|
(1S)-1,5-脫水-1-C-[4-氯-3-[[4-[[(3S)-四氫-3-呋喃基]氧基]苯基]甲基]苯基]-D-葡萄糖醇;艾帕列凈;依帕列凈;恩格列嗪;恩格列嗪 EMPAGLIFLOZIN;恩格列凈/依帕列凈;恩格列凈;艾帕列凈/依帕列凈雜質(zhì)
|
864070-44-0
|
|
SalMeterol IMpurity
|
沙美特羅雜質(zhì)
|
144391-74-2
|
|
Montelukast iMpurity
|
孟魯司特雜質(zhì)
|
|
|
Methotrexate impurity
|
甲氨蝶呤雜質(zhì)
|
|
|
Paliperidone impurity
|
帕潘立酮雜質(zhì)
|
|
|
Naltrexone hydrochloride impurity A
|
鹽酸納曲酮雜質(zhì)A
|
|
|
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene
|
坎格列凈中間體;坎格列凈的中間體;2-(2-甲基-5-溴芐基)-5-(4-氟苯)噻吩(坎格列凈中間體);卡格列凈 中間體 KG-1.1
|
898566-17-1
|
|
COLURACETAM
|
N-(2,3-二甲基-5,6,7,8-四氫呋喃并[2,3-B]喹啉-4-基)-2-(2-氧代吡咯烷-1-基)乙酰胺;考拉西坦
|
135463-81-9
|
|
Methyl 2,3,4-trifluoro-5-nitrobenzoate
|
2,3,4-三氟-5-硝基苯甲酸甲酯
|
918321-24-1
|
|
Pioglitazone BroMo IMpurity
|
吡格列酮雜質(zhì)
|
|
|
Vortioxetine
|
沃替西汀
|
508233-74-7
|
|
ABT-199
|
ABT-199
|
1257044-40-8
|
|
(2S)-2-Amino-4-methyl-1-((2R)-2-methyloxiranyl)-1-pentanone Trifluoroacetate
|
卡非佐米側(cè)鏈中間體
|
247068-85-5
|
|
CO-1686
|
CO-1686 中間體三
|
1021426-42-5
|
|
(E)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid
|
奧貝膽酸中間體-3;3A羥基-7氧代-膽烷酸甲酯;奧貝膽酸中間體;奧貝膽酸中間體 OB-3
|
1516887-33-4
|
|
Ampicillin impurity
|
氨芐青霉素雜質(zhì)
|
|
|
DONEPEZIL IMP
|
多奈哌齊雜質(zhì)
|
923571-16-8
|
|
Zolpidem
|
唑吡坦雜質(zhì)
|
365213-58-7
|
|
TaMsulosin EP IMpurity
|
坦索羅辛雜質(zhì)
|
1798904-07-0
|
|
Stugeron
|
桂利嗪雜質(zhì)
|
298-57-7
|
|
REPAGLINIDE RELATED COMPOUND C (25 MG) ((S)-2-ETHOXY-4-[2-[[2-PHENYL-1 -[2-(1 -PIPERIDINYL)PHE-NYL]ETHYL]AMINO]-2-OXOETHYL] BENZOIC ACID)
|
瑞格列奈雜質(zhì)
|
107362-12-9
|
|
(S)-(+)-2-Chlorophenylglycine methyl ester
|
S-鄰氯苯甘氨酸甲酯酒石酸鹽
|
141109-14-0
|
|
LY2835219
|
LY2835219中間體二
|
1180132-17-5
|
|
2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene
|
2-(2-甲基-5-溴芐基)-5-(4-氟苯)噻吩;2-[(5-溴-2-甲基苯基)甲基]-5-(4-氟苯基)噻吩;坎格列凈中間體1
|
1030825-20-7
|
|
Vortioxetine (Lu AA21004) HBr
|
沃替西汀氫溴酸鹽
|
960203-27-4
|
|
LY2835219
|
阿貝西利
|
1231929-97-7
|
|
Oxaliplatin impurity
|
奧沙利鉑雜質(zhì)
|
|
|
Diacerein impurity
|
雙醋瑞因雜質(zhì)
|
|
|
NiMesulide EP IMpurity
|
尼美舒利雜質(zhì)
|
38880-53-4
|
|
4-Amino-3-chlorophenol hydrochloride
|
3-氯-4-氨基苯酚鹽酸鹽
|
52671-64-4
|
|
WZ3146
|
WZ3146
|
1214265-56-1
|
|
Rucaparib
|
瑞卡帕布（AG-014699）
|
459868-92-9
|
|
Edoxaban
|
依度沙班
|
1229194-11-9
|
|
Rosuvastatin IMpurity (5-Oxo Rosuvastatin tert-Butyl Ester)
|
瑞舒伐他汀雜質(zhì)
|
854898-53-6
|
|
Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol]
|
喹硫平雜質(zhì)
|
2206135-50-2
|
|
Ondansetron IMpurity
|
恩丹西酮雜質(zhì)
|
|
|
Empagliflozin Impurity
|
恩格列凈雜質(zhì)
|
2253771-11-6
|
|
Ramipril impurity
|
雷米普利雜質(zhì)
|
|
|
Dioxin impurity
|
潘生丁雜質(zhì)
|
|
|
Entecavir Impurity
|
恩替卡韋雜質(zhì)
|
1333204-94-6
|
|
Naltrexone hydrochloride impurity B
|
鹽酸納曲酮雜質(zhì)B
|
|
|
Rivastigmine
|
卡巴拉汀雜質(zhì)
|
123441-03-2
|
|
TOPOTECANACETATE
|
拓?fù)涮婵惦s質(zhì)
|
123948-88-9
|
|
LY2835219
|
LY2835219中間體四
|
1231930-33-8
|
|
O-Isobutyryl (R)-Fesoterodine
|
弗斯特羅定雜質(zhì)
|
1208313-13-6
|
|
LY2835219
|
LY2835219中間體三
|
1231930-37-2
|
|
Mirtazapine iMpurity
|
米氮平雜質(zhì)
|
1188331-80-7
|
|
Sitagliptin iMpurity
|
西他列汀雜質(zhì)
|
1675201-14-5
|
|
Paroxetine IMpurity
|
帕羅西汀雜質(zhì)
|
|
|
PiroxicaM IMpurity ( N-(2-Pyridinyl)oxaMic Acid )
|
吡羅昔康雜質(zhì)
|
|
|
(4R,5S)-4,5-Dichloro-4,5-dimethyl-1,3-dioxolan-2-one
|
奧美沙坦雜質(zhì)
|
116857-04-6
|
|
Entacapone
|
恩他卡朋雜質(zhì)
|
|
|
nifedipine iMpurity
|
硝苯地平雜質(zhì)
|
|
|
TICARCILLIN IMPURITY
|
替卡西林雜質(zhì)
|
|